Unlike Carney complex, many of the pathogenic variants in PRKAR1A that are found in patients with acrodysostosis may lead to decreased sensitivity to cAMP, resulting in a dominant negative effect on PKA activity (reviewed in Michot 2018 [98]). The gene discussed is PRKAR1A; the disease is acrodysostosis.